HomeCompareYLLXF vs JNJ

YLLXF vs JNJ: Dividend Comparison 2026

YLLXF yields 24.69% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YLLXF wins by $76.9K in total portfolio value
10 years
YLLXF
YLLXF
● Live price
24.69%
Share price
$8.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$97.0K
Annual income
$10,813.42
Full YLLXF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — YLLXF vs JNJ

📍 YLLXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYLLXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YLLXF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YLLXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YLLXF
Annual income on $10K today (after 15% tax)
$2,098.77/yr
After 10yr DRIP, annual income (after tax)
$9,191.41/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, YLLXF beats the other by $8,487.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YLLXF + JNJ for your $10,000?

YLLXF: 50%JNJ: 50%
100% JNJ50/50100% YLLXF
Portfolio after 10yr
$58.5K
Annual income
$5,820.60/yr
Blended yield
9.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

YLLXF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
231.5
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YLLXF buys
0
JNJ buys
0
No recent congressional trades found for YLLXF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYLLXFJNJ
Forward yield24.69%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$97.0K$20.0K
Annual income after 10y$10,813.42$827.78
Total dividends collected$61.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: YLLXF vs JNJ ($10,000, DRIP)

YearYLLXF PortfolioYLLXF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,169$2,469.14$10,676$355.77+$2.5KYLLXF
2$17,130$3,038.91$11,407$389.39+$5.7KYLLXF
3$22,023$3,694.30$12,198$426.53+$9.8KYLLXF
4$28,004$4,438.90$13,056$467.62+$14.9KYLLXF
5$35,239$5,275.06$13,987$513.12+$21.3KYLLXF
6$43,910$6,203.71$14,998$563.56+$28.9KYLLXF
7$54,208$7,224.40$16,098$619.52+$38.1KYLLXF
8$66,337$8,335.26$17,295$681.69+$49.0KYLLXF
9$80,514$9,533.09$18,599$750.82+$61.9KYLLXF
10$96,964$10,813.42$20,022$827.78+$76.9KYLLXF

YLLXF vs JNJ: Complete Analysis 2026

YLLXFStock

Yellow Cake plc, a specialist company, operates in the uranium sector. It is involved in the purchase and holding of uranium oxide concentrates; and exploitation of other uranium-related opportunities. The company was incorporated in 2018 and is headquartered in Saint Helier, Jersey.

Full YLLXF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this YLLXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YLLXF vs SCHDYLLXF vs JEPIYLLXF vs OYLLXF vs KOYLLXF vs MAINYLLXF vs ABBVYLLXF vs MRKYLLXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.